Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma

NCT03143049 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Relapse Multiple Myeloma

Interventions

DRUG: PCD
DRUG: PD

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]
[object Object]